MONTREAL, CANADA -- (MARKET WIRE) -- September 13, 2006 -- ART Advanced Research Technologies Inc. (ART)(TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today findings gleaned from the analysis of tissue characterization data, from a multi-site clinical study using the SoftScan® optical imaging device. In this study, lesions were identified on mammograms by a radiologist and characterized on their co-localized optical images through the SoftScan review workstation.
